CVA Family Office’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$290K Sell
3,159
-61
-2% -$5.34K 0.03% 276
2026
Q1
$274K Buy
3,220
+27
+0.8% +$2.41K 0.03% 262
2025
Q4
$252K Buy
3,193
+261
+9% +$20.5K 0.03% 263
2025
Q3
$234K Sell
2,932
-44
-1% -$3.75K 0.03% 264
2025
Q2
$270K Sell
2,976
-243
-8% -$22.2K 0.04% 243
2025
Q1
$302K Buy
3,219
+179
+6% +$16K 0.05% 212
2024
Q4
$276K Buy
3,040
+104
+4% +$9.92K 0.04% 223
2024
Q3
$305K Buy
2,936
+9
+0.3% +$917 0.05% 196
2024
Q2
$284K Buy
2,927
+52
+2% +$4.8K 0.05% 197
2024
Q1
$259K Buy
2,875
+6
+0.2% +$508 0.05% 208
2023
Q4
$229K Buy
+2,869
New +$216K 0.04% 218
2023
Q3
– Sell
-2,720
Closed -$210K – 362
2023
Q2
$210K Buy
2,720
+213
+8% +$16.5K 0.04% 215
2023
Q1
$188K Sell
2,507
-95
-4% -$7.06K 0.04% 227
2022
Q4
$205K Buy
2,602
+185
+8% +$13.9K 0.05% 206
2022
Q3
$170K Buy
2,417
+400
+20% +$31.4K 0.05% 186
2022
Q2
$162K Sell
2,017
-240
-11% -$18.8K 0.04% 186
2022
Q1
$171K Buy
2,257
+740
+49% +$58.6K 0.04% 189
2021
Q4
$129K Buy
1,517
+895
+144% +$69.9K 0.03% 207
2021
Q3
$48K Sell
622
-1,190
-66% -$94.5K 0.03% 187
2021
Q2
$147K Hold
1,812
– – 0.04% 183
2021
Q1
$143K Buy
1,812
+1,190
+191% +$93.3K 0.05% 144
2020
Q4
$53K Hold
622
– – 0.03% 189
2020
Q3
$48K Buy
622
+335
+117% +$25.5K 0.03% 187
2020
Q2
$21K Buy
287
+225
+363% +$16K 0.02% 214
2020
Q1
$4K Buy
+62
New +$4.37K ﹤0.01% 278

Other funds holding CL

CVA Family Office's CL Position: Q2 2026 in Review

CVA Family Office reduced its Colgate-Palmolive (CL) stake by 1.9% in Q2 2026, selling an estimated $5.34K and leaving 3,159 shares worth $290K. The position accounts for 0.03% of the portfolio, ranked #276.

CVA Family Office first reported a position in CL in Q1 2020 and has held it in 25 quarters since. The position peaked at $305K in Q3 2024. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • CVA Family Office held 3,159 shares of Colgate-Palmolive worth $290K as of Q2 2026.
  • CVA Family Office sold 61 Colgate-Palmolive shares in Q2 2026, an estimated $5.34K.
  • Colgate-Palmolive made up 0.03% of CVA Family Office's portfolio in Q2 2026, its #276 holding.
  • CVA Family Office first reported a position in Colgate-Palmolive in Q1 2020 and has held it in 25 quarters since.
  • CVA Family Office's Colgate-Palmolive position peaked at $305K in Q3 2024.
  • 2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.